ABO, ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase, 28
N. diseases: 73; N. variants: 159
Source: INFERRED ×
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Laboratory Procedure | 2 | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2019 | ||||||
|
phenotype | Laboratory Procedure | 6 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||
|
phenotype | Laboratory Procedure | 7 | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | ||||||
|
phenotype | Laboratory or Test Result | 7 | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | ||||||
|
disease | Digestive System Diseases | Disease or Syndrome | 10 | 0.430 | None | 1.000 | 1 | 2 | 1979 | 2013 | |||||
|
phenotype | Laboratory Procedure | 14 | 0.100 | None | 1.000 | 1 | 3 | 2013 | 2013 | ||||||
|
phenotype | Laboratory Procedure | 15 | 0.100 | None | 1.000 | 2 | 3 | 2010 | 2019 | ||||||
|
phenotype | Laboratory Procedure | 16 | 0.100 | None | 1.000 | 1 | 3 | 2013 | 2013 | ||||||
|
phenotype | Laboratory Procedure | 17 | 0.100 | None | 1.000 | 3 | 3 | 2012 | 2018 | ||||||
|
phenotype | Laboratory Procedure | 17 | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2012 | ||||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 19 | 0.120 | None | 1.000 | 1 | 1 | 1999 | 2018 | |||||
|
disease | Digestive System Diseases; Neoplasms; Endocrine System Diseases | Neoplastic Process | 19 | 0.500 | None | 0.960 | 1 | 1 | 2009 | 2018 | |||||
|
disease | Infections | Disease or Syndrome | 20 | 0.200 | None | 0.923 | 2 | 11 | 2007 | 2019 | |||||
|
disease | Digestive System Diseases; Neoplasms | Neoplastic Process | 23 | 0.200 | None | 1.000 | 1 | 1 | 1987 | 2019 | |||||
|
phenotype | Laboratory Procedure | 23 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||
|
phenotype | Laboratory Procedure | 27 | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||
|
phenotype | Laboratory Procedure | 29 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||
|
phenotype | Laboratory Procedure | 32 | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||
|
phenotype | Laboratory Procedure | 39 | 0.100 | None | 1.000 | 1 | 10 | 2011 | 2011 | ||||||
|
phenotype | Laboratory Procedure | 42 | 0.100 | None | 1.000 | 4 | 5 | 2008 | 2018 | ||||||
|
phenotype | Laboratory Procedure | 42 | 0.100 | None | 1.000 | 2 | 2 | 2013 | 2015 | ||||||
|
disease | Digestive System Diseases; Neoplasms; Endocrine System Diseases | Neoplastic Process | 47 | 0.200 | None | 0.962 | 4 | 2 | 2009 | 2018 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 47 | 0.130 | None | 1.000 | 1 | 1 | 2014 | 2019 | |||||
|
group | Laboratory Procedure | 51 | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||
|
phenotype | Laboratory Procedure | 55 | 0.100 | None | 1.000 | 6 | 59 | 2010 | 2019 |